Phase 2 Advanced NSCLC Clinical Trials
9 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–9 of 9 trials
Recruiting
Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
Squamous Cell CarcinomaAdvanced Non-Small Cell Lung CancerAdvanced NSCLC+2 more
National Cancer Institute (NCI)85 enrolled1 locationNCT02133196
Recruiting
Phase 2
Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy
Advanced NSCLC
Shanghai Junshi Bioscience Co., Ltd.66 enrolled18 locationsNCT06924606
Recruiting
Phase 2
A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients
First-line Advanced NSCLC Patients
Shenyang Sunshine Pharmaceutical Co., LTD.240 enrolled1 locationNCT07171606
Recruiting
Phase 2
Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation
Metastatic Lung CancerAdvanced NSCLC
Mirati Therapeutics Inc.90 enrolled166 locationsNCT05609578
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor
Advanced NSCLCAdvanced Endometrial Cancer
Huabo Biopharm Co., Ltd.282 enrolled14 locationsNCT06758557
Recruiting
Phase 2
Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment
Advanced NSCLC
The First Affiliated Hospital of Nanchang University10 enrolled2 locationsNCT06751901
Recruiting
Phase 2
Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment
Advanced NSCLC
The First Affiliated Hospital of Nanchang University10 enrolled2 locationsNCT06751849
Recruiting
Phase 2
PD-1 Combined With Pyrotinib for Chemotherapy Failure HER2 Insertion Mutation Advanced NSCLC
HER2 Insertion Mutation Positive Advanced NSCLC
Yongchang Zhang30 enrolled1 locationNCT04144569
Recruiting
Phase 2
A Phase II Study of SSGJ-707 Combination Therapy in Advanced NSCLC Patients
First-line Advanced NSCLC Patients
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.235 enrolled1 locationNCT06412471